Wikidata

(Q64352464)

English

Difference in Efficacy of Natalizumab Versus Fingolimod for the Treatment of Multiple Sclerosis

clinical trial

In more languages

Statements

short name
BEST-MS (English)
0 references
title
Essai de Phase IV, Multicentrique, Ouvert, Visant à Tester la différence d'efficacité du Natalizumab, Versus le Fingolimod, 2 médicaments Ayant Une AMM Pour le Traitement de la sclérose en Plaques (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
France
0 references
Germany
0 references
Spain
0 references
start time
November 2013
0 references
end time
October 2017
0 references
number of participants
600
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64352464&oldid=1857677348"